School of Pharmaceutical Sciences Geneva-Lausanne (EPGL), University of Geneva, University of Lausanne, Switzerland
Keywords of expertise: 1. Biopharmaceutics, 2. Nanomedicines: drug & vaccine carriers, 3. Therapeutic protein formulation
Golden Paragraph: Gerrit Borchard is a professor of Biopharmaceutics at the School of Pharmaceutical Sciences Geneva-Lausanne (EPGL) at the University of Geneva (Switzerland). His primary interest in SimInhale is the formulation of vaccine and drug carriers as nano-medicines adapted to the application by inhalation. Several alternative technologies need to be assessed with regard to optimization of efficacy, and lowering of costs and toxicity.